HJoachimDeegMD

PubMed

• Core‐binding factor acute myeloid leukemia with inv(16): Older age and high white blood cell count are risk factors for treatment failure
  Celalettin Ustun, Elizabeth A. Morgan, Ethan M. Ritz, Hanne Vestergaard, Sheeja T. Pullarkat, Philip M. Kluin, Robert S. Ohgami, Linda B. Baughn, Young L. Kim, Nam K. ...> ;International Journal of Laboratory Hematology. 2021 Feb 1
• Prediction of Acute Graft versus Host Disease and Relapse by Endogenous Metabolomic Compounds in Patients Receiving Personalized Busulfan-Based Conditioning.
  Jeannine S. McCune, Jožefa S. McKiernan, Erik M. van Maarseveen, Alwin D. R. Huitema, Timothy W. Randolph, H. Joachim Deeg, Ryotaro Nakamura, K. Scott Baker> ;Journal of Proteome Research. 2021 Jan 1
• Individuals, Boundaries, and Graft-versus-Host Disease.
  H. Joachim Deeg> ;Biology of Blood and Marrow Transplantation. 2020 Dec 1
• Genetic factors rather than blast reduction determine outcomes of allogeneic HCT in BCR-ABL-negative MPN in blast phase
  Vikas Gupta, James A. Kennedy, Jose-Mario Capo-Chichi, Soyoung Kim, Zhen-Huan Hu, Edwin P. Alyea, Uday R. Popat, Ronald Sobecks, Bart L. Scott, Aaron T. Gerds, Rachel ...> ;Blood Advances. 2020 Nov 10
• Silver lining: reduced relapse with chronic GVHD after transplant for MDS
  Ashley M. Eckel, H. Joachim Deeg> ;Clinical Cancer Research. 2020 Oct 16
• 1 citations
  Conditioning Intensity, Pre-Transplant Flow Cytometric Measurable Residual Disease, and Outcome in Adults with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoiet...
  Linde M. Morsink, Brenda M. Sandmaier, Megan Othus, Raffaele Palmieri, Noa Granot, Evandro D. Bezerra, Brent L. Wood, Marco Mielcarek, Gary Schoch, Chris Davis, Mary E...> ;Cancers. 2020 Aug 19
• Diagnosis of pulmonary hypertension by noninvasive methods in hematopoietic cell transplant patients with myelofibrosis.
  Rachel B. Salit, Kelsey Baker, Rachael Edwards, Greta Tobin, Gregory Kicska, Ted Gooley, H. Joachim Deeg, Bart L. Scott, Guang-Shing Cheng> ;Bone Marrow Transplantation. 2020 Aug 1
• Treosulfan-based conditioning is feasible and effective for cord blood recipients: a phase 2 multicenter study.
  Filippo Milano, Jonathan A. Gutman, H. Joachim Deeg, Eneida R. Nemecek, Joachim Baumgart, Laurel A. Thur, Ann Dahlberg, Rachel B. Salit, Corinne Summers, Frederick R. ...> ;Blood Advances. 2020 Jul 28
• 1 citations
  Early Mixed Lymphoid Donor/Host Chimerism is Associated with Improved Transplant Outcome in Patients with Primary or Secondary Myelofibrosis
  H. Joachim Deeg, Rachel B. Salit, Tim Monahan, Gary Schoch, Chris McFarland, Bart L. Scott, Barry E. Storer> ;Biology of Blood and Marrow Transplantation. 2020 Jul 18
• 1 citations
  Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: Improved outcomes over two decades.
  Jason P. Cooper, Barry E. Storer, Noa Granot, Boglark Gyurkocza, Mohamed L. Sorror, Thomas R. Chauncey, Judith A. Shizuru, Georg-Nikolaus Franke, Michael B. Maris, Mic...> ;Haematologica. 2020 Jun 4
• 42 citations
  Impact of Conditioning Intensity of Allogeneic Transplantation for Acute Myeloid Leukemia With Genomic Evidence of Residual Disease
  Christopher S. Hourigan, Laura W. Dillon, Gege Gui, Brent R. Logan, Mingwei Fei, Jack Ghannam, Yuesheng Li, Abel Licon, Edwin P. Alyea, Asad Bashey, H. Joachim Deeg, S...> ;Journal of Clinical Oncology. 2020 Apr 20
• 3 citations
  Targeted Sequencing Improves DIPSS-Plus Prognostic Scoring in Myelofibrosis Patients Undergoing Allogeneic Transplantation.
  Emily A. Stevens, Isaac C. Jenkins, Lan Beppu, Qing Zhang, Rachel B. Salit, Keith R. Loeb, H. Joachim Deeg, Jerald P. Radich> ;Biology of Blood and Marrow Transplantation. 2020 Jul 1
• 3 citations
  Impact of clinical, cytogenetic, and molecular profiles on long-term survival after transplantation in patients with chronic myelomonocytic leukemia
  Janghee Woo, Dae Ro Choi, Barry E. Storer, Cecilia Yeung, Anna B. Halpern, Rachel B. Salit, Mohamed L. Sorror, David W. Woolston, Tim Monahan, Bart L. Scott, H. Joachi...> ;Haematologica. 2020 Mar 1
• 22 citations
  Survival, Nonrelapse Mortality, and Relapse-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: Comparing 2003-2007 Versus 2013-2017 Cohorts.
  George B. McDonald, Brenda M. Sandmaier, Marco Mielcarek, Mohamed L. Sorror, Steven A. Pergam, Guang-Shing Cheng, Sangeeta Hingorani, Michael Boeckh, Mary D. Flowers, ...> ;Annals of Internal Medicine. 2020 Feb 18
• Elevated TWIST1 expression in myelodysplastic syndromes/ acute myeloid leukemia reduces efficacy of hypomethylating therapy with decitabine.
  Li, H., Wang, Y., Pang, X., Xie, C., Deeg, H. J., Wang, H., Wan, T., Wu, J., Guan, F., Li, X.> ;Haematologica. 2020 Feb 1
• Elevated TWIST1 expression in myelodysplastic syndromes/acute myeloid leukemia reduces efficacy of hypomethylating therapy with decitabine.
  Hongjiao Li, Yi Wang, Xingchen Pang, Chenglian Xie, Joachim H Deeg, Hui Wang, Ting Wan, Jinpeng Wu, Feng Guan, Xiang Li> ;Haematologica. 2020 Jan 30
• 3 citations
  Impact of pretransplant measurable residual disease on the outcome of allogeneic hematopoietic cell transplantation in adult monosomal karyotype AML
  Linde M. Morsink, Megan Othus, Evandro D. Bezerra, Brent L. Wood, Min Fang, Brenda M. Sandmaier, Marco Mielcarek, Gary Schoch, Rainer Storb, H. Joachim Deeg, Frederick...> ;Leukemia. 2020 Jan 23
• 9 citations
  Pre-hematopoietic cell transplant Ruxolitinib in patients with primary and secondary myelofibrosis.
  Rachel B. Salit, Bart L. Scott, Emily A. Stevens, Kelsey Baker, Ted Gooley, H. Joachim Deeg> ;Bone Marrow Transplantation. 2020 Jan 1
• 3 citations
  Comparative analysis of total body irradiation (TBI)-based and non-TBI-based myeloablative conditioning for acute myeloid leukemia in remission with or without measura...
  Linde M. Morsink, Evandro D. Bezerra, Megan Othus, Brent L. Wood, Min Fang, Brenda M. Sandmaier, Marco Mielcarek, H. Joachim Deeg, Gary Schoch, Frederick R. Appelbaum,...> ;Leukemia. 2020 Jun 1
• Allogeneic Hematopoietic Cell Transplantation and Other Expensive Cellular Therapies: A Miracle for the Few but Off Limits to Many?
  Nandita Khera, H. Joachim Deeg, Eric Kodish, Damiano Rondelli, Navneet S. Majhail> ;Journal of Clinical Oncology. 2020 Apr 20
• 19 citations
  Total body irradiation dose and risk of subsequent neoplasms following allogeneic hematopoietic cell transplantation
  K. Scott Baker, Wendy M. Leisenring, Pamela Goodman, Ralph P. Ermoian, Mary E.D. Flowers, Gary Schoch, Rainer Storb, Brenda M. Sandmaier, H. Joachim Deeg> ;Blood. 2019 Jun 27
• 8 citations
  Total body irradiation dose escalation decreases risk of progression and graft rejection after hematopoietic cell transplantation for myelodysplastic syndromes or myel...
  Federico Monaco, Bart L. Scott, Thomas R. Chauncey, Finn B. Petersen, Barry E. Storer, Frédéric Baron, Mary E.D. Flowers, H. Joachim Deeg, David G. Maloney, Rainer Sto...> ;Haematologica. 2019 Jun 1
• 2 citations
  Outcomes of Patients With Therapy-Related MDS After Chemoimmunotherapy for Chronic Lymphocytic Leukemia Compared With Patients With De Novo MDS: A Single-Institution E...
  Jason P. Cooper, Sirin Khajaviyan, Stephen D. Smith, David G. Maloney, Andrei R. Shustov, Edus H. Warren, Lorinda Soma, Ryan C. Lynch, Chaitra S. Ujjani, Brian G. Till...> ;Clinical Lymphoma, Myeloma & Leukemia. 2019 Jun 1
• 4 citations
  The National MDS Natural History Study: design of an integrated data and sample biorepository to promote research studies in myelodysplastic syndromes.
  Mikkael A. Sekeres, Steven D. Gore, Donald M. Stablein, Nancy DiFronzo, Gregory A. Abel, Amy E. DeZern, Jesse D. Troy, Dana E. Rollison, John W. Thomas, Myron A. Wacla...> ;Leukemia & Lymphoma. 2019 May 21
• Asymmetric dimethylarginine – a prognostic marker for transplant outcome?
  Janghee Woo, H. Joachim Deeg> ;Haematologica. 2019 Apr 1
• Join now to see all

Journal Articles

• Treatment of refractory ITP and Evans syndrome by haematopoietic cell transplantation: is it indicated, and for whom?  
  Vaughn,J.E., Anwer,F., Deeg,H.J., Vox Sang., 1/1/2016
• Number of courses of induction therapy independently predicts outcome after allogeneic transplantation for acute myeloid leukemia in first morphological remission  
  Walter,R.B., Sandmaier,B.M., Storer,B.E., Godwin,C.D., Buckley,S.A., Pagel,J.M., Sorror,M.L., Deeg,H.J., Storb,R., Appelbaum,F.R., Biol Blood Marrow Transplant, 1/1/2015
• Reevaluation of the pretransplant assessment of mortality score after allogeneic hematopoietic transplantation  
  Au,B.K., Gooley,T.A., Armand,P., Fang,M., Madtes,D.K., Sorror,M.L., Boeckh,M.J., Gibson,C.J., Deeg,H.J., Storb,R., Appelbaum,F.R., Chien,J.W., Martin,P.J., Biol Blood Marrow Transplant, 1/1/2015
• Treatment ethics, quality of life and health economics in the management of hematopoietic malignancies in older patients  
  Deeg,H.J., Bone Marrow Transplant, 1/1/2015
• Impact of allogeneic stem cell trans-plantation on survival of patients less than 65 years of age with primary myelofibrosis  
  Kroger,N., Giorgino,T., Scott,B.L., Ditschkowski,M., Alchalby,H., Cervantes,F., Vannucchi,A., Cazzola,M., Morra,E., Zabelina,T., Maffioli,M., Pereira,A., Beelen,D., De..., Blood, 1/1/2015
• Therapy for hematologic cancers in older patients, quality of life, and health economics: difficult decisions  
  Deeg,H.J., Steuten,L.M., JAMA Oncology, 1/1/2015
• Relapse after allogeneic hematopoietic cell transplantation for myelodysplastic syndromes: analysis of late relapse using comparative karyotype and chromosome genome a...  
  Yeung,C.C., Gerds,A.T., Fang,M., Scott,B.L., Flowers,M.E., Gooley,T., Deeg,H.J., Biol Blood Marrow Transplant, 1/1/2015
• Quantitative analysis of glycans, related genes, and proteins in two human bone marrow stromal cell lines using an integrated strategy  
  Li,X., Li,D., Pang,X., Yang,G., Deeg,H.J., Guan,F, Exp. Hematol, 1/1/2015
• Hematopoietic cell transplantation for myelodysplastic syndrome  
  Deeg,H.J., American Society of Clinical Oncology Educational Book, 1/1/2015
• SRSF2 mutations contribute to myelodysplasia by mutant-specific effects on exon recognition  
  Kim,E., Ilagan,J.O., Liang,Y., Daubner,G.M., Lee,S.C., Ramakrishnan,A., Li,Y., Chung,Y.R., Micol,J.B., Murphy,M.E., Cho,H., Kim,M.K., Zebari,A.S., Aumann,S., Park,C.Y...., Cancer Cell, 1/1/2015
• Severe refractory immune thrombocytopenia successfully treated with high-dose pulse cyclophosphamide and eltrombopag  
  Anwer,F., Yun,S., Nair A., Ahmad,Y., Krishnadashan,R., Deeg,H.J., Case Reports in Hematology, 1/1/2015
• In support of a patient-driven initiative and petition to lower the high price of cancer drugs (Commentary)  
  Tefferi,A., Kantarjian,H., Rajkumar,S.V., Baker,L.H., Abkowitz,J.L., Adamson,J.W., Advani,R.H., Allison,J., Antman,K.H., Bast,R.C., Jr., Bennett,J.M., Benz,E.J., Jr., ..., Mayo Clin. Proc, 1/1/2015
• A novel retroviral mutagenesis screen identifies prognostic genes in RUNX1 mediated myeloid leukemogenesis  
  Rae,D.T., Hocum,J.D., Bii,V., Deeg,H.J., Trobridge,G.D., Oncotarget, 1/1/2015
• Cyclophosphamide conditioning in patients with severe aplastic anaemia given unrelated marrow transplantation: a phase 1-2 dose de-escalation study  
  Anderlini,P., Wu,J., Gersten,I., Ewell,M., Tolar,J., Antin,J.H., Adams,R., Arai,S., Eames,G., Horwitz,M.E., McCarty,J., Nakamura,R., Pulsipher,M.A., Rowley,S., Leifer,..., The Lancet Haematology, 1/1/2015
• Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN International Working Group  
  Kroger,N.M., Deeg,H.J., Olavarria,E., Niederwieser,D., Bacigalupo,A., Barbui,T., Rambaldi,A., Mesa,R., Tefferi,A., Griesshammer,M., Gupta,V., Harrison,C., Alchalby,H.,..., Leukemia, 1/1/2015
• Hematopoietic cell transplantation as curative therapy for patients with myelofibrosis: long-term success in all age groups  
  Deeg,H.J., Bredeson,C., Farnia,S., Ballen,K., Gupta,V., Mesa,R.A., Popat,U., Hari,P., Saber,W., Seftel,M., Tamari,R., Petersdorf,E, Biol Blood Marrow Transplant, 1/1/2015
• Treosulfan and radiation-induced cytotoxicity in myeloid cell lines and primary MDS cells  
  Zang,D.Y., Holman,Z., Marcondes,A.M., Deeg,H.J., Jacobs Journal of Hematology, 1/1/2015
• Second allogeneic hematopoietic cell transplantation for patients with Fanconi anemia and bone marrow failure  
  Ayas,M., Eapen,M., Le-Rademacher,J., Carreras,J., Abdel-Azim,H., Alter,B.P., Anderlini,P., Battiwalla,M., Bierings,M., Buchbinder,D.K., Bonfim,C., Camitta,B.M., Fasth,..., Biol Blood Marrow Transplant, 1/1/2015
• Murine xenogeneic models of myelodysplastic syndrome (MDS): an essential role for stroma cells  
  Li,X., Deeg,H.J, Exp. Hematol, 1/1/2014
• Effect of race on outcomes after allogeneic hematopoietic cell transplantation for severe aplastic anemia  
  Eckrich,M.J., Ahn,K.W., Champlin,R.E., Coccia,P., Godder,K., Horan,J., Margolis,D., Deeg,H.J., Eapen,M, Am. J. Hematol, 1/1/2014
• Treosulfan, fludarabine, and 2-Gy total body irradiation followed by allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome and acute ...  
  Gyurkocza,B., Gutman,J., Nemecek,E.R., Bar,M., Milano,F., Ramakrishnan,A., Scott,B., Fang,M., Wood,B., Pagel,J.M., Baumgart,J., Delaney,C., Maziarz,R.T., Sandmaier,B.M..., Biol Blood Marrow Transplant, 1/1/2014
• Prognostic factors and outcomes of severe gastrointestinal GVHD after allogeneic hematopoietic cell transplantation  
  Castilla-Llorente,C., Martin,P.J., McDonald,G.B., Storer,B.E., Appelbaum,F.R., Deeg,H.J., Mielcarek,M., Shulman,H., Storb,R., Nash,R.A., Bone Marrow Transplant, 1/1/2014
• Outpatient bendamustine and idarubicin for upfront therapy of elderly acute myeloid leukaemia/myelodysplastic syndrome: a phase I/II study using an innovative statisti...  
  Lionberger,J.M., Pagel,J.M., Sandhu,V.K., Xie,H., Shadman,M., Mawad,R., Boehm,A., Dean,C., Shannon-Dorcy,K., Scott,B.L., Deeg,H.J., Becker,P.S., Hendrie,P.C., Walter,R..., Br. J. Haematol, 1/1/2014
• Janus kinase inhibitors and allogeneic stem cell transplantation for myelofibrosis  
  Gupta,V., Gotlib,J., Radich,J.P., Kroger,N.M., Rondelli,D., Verstovsek,S., Deeg,H.J., Biol Blood Marrow Transplant, 1/1/2014
• Acute phase protein, a1-antitrypsin--a novel regulator of angiopoietin-like protein 4 transcription and secretion  
  Frenzel,E., Wrenger,S., Immenschuh,S., Koczulla,R., Mahadeva,R., Deeg,H.J., Dinarello,C.A., Welte,T., Marcondes,A.M., Janciauskiene,S., J. Immunol, 1/1/2014
• Join now to see all

Books/Book Chapters

• Thomas' Hematopoietic Cell Transplantation 
  Chapter: Hematopoietic cell transplantation for myelodysplastic syndromes and myeloproliferative neoplasms 
  Page 613 - 624Deeg,H.J.Editors: Forman,S.J., Negrin,R.S., Antin,J.H., and Appelbaum,F.R..Wiley-BlackwellEdition 5th,2016
• Novel Insights into Myelofibrosis Pathophysiology and Treatment 
  Chapter: When and how to transplant patients with myelofibrosis 
  Deeg,H.J., Sala-Torra,O., Scott,B.L.Editors: Verstovsek,S..Future Science Group, London2015
• Hamatopoietische Stammzellen 
  Chapter: Transplantatversagen, krankheitsrezidiv, zweittransplantation 
  Page 196 - 199Platzbecker,U., Deeg,H.J.Editors: Herr,W., Theobald,M., Ehninger,G., Einsele,H., and Meyer,R.G.Deutscher arzte-Verlag GmbH, Koln2015
• Hamatopoietische Stammzellen 
  Chapter: Sekundarmalignome 
  Page 200 - 206Wagner,E.M., Deeg,H.J.Editors: Herr,W., Theobald,M., Ehninger,G., Einsele,H., and Meyer,R.G..Deutscher arzte-Verlag GmbH, Koln2015
• Neoplastic Diseases of the Blood 
  Chapter: Alternative sources of hematopoietic stem cells and their clinical applications 
  Page 1289 - 1306Gutman,J., Heimfeld,S., Deeg,H.J.Editors: Wiernik,P., Goldman,J., Dutcher,J., and Kyle,R.Cambridge University Press, Cambridge, UKEdition Fift,2013
• Myelodysplastic Syndromes 
  Editors: Deeg,H.J., Bowen,D.T., Gore,S.D., Haferlach,T., Le Beau,M.M., Niemeyer,C..Springer-Verlag, Berlin Heidelberg2013
• Myelodysplastic Syndromes 
  Chapter: MDS stem cell biology 
  Page 73 - 84Greenblatt,S.M., Deeg,H.J., Nimer,S.D.Editors: Deeg,H.J., Bowen,D.T., Gore,S.D., Haferlach,T., Le Beau,M.M., and Niemeyer,C..Springer-Verlag, Berlin Heidelberg2013
• Hematopoietic cell transplantation (HCT). 
  Chapter: Hematopoietic cell transplantation (HCT). 
  Page 211 - 228Deeg,H.JEditors: Deeg,H.J., Bowen,D.T., Gore,S.D., Haferlach,T., Le Beau,M.M., and Niemeyer,C..Springer-Verlag, Berlin Heidelberg2013
• Clinical Decision Support: Hematology 
  Chapter: Hematopoeitic cell transplantation for non-malignant diseases 
  Deeg,H.J.Editors: Benz,E.J., Berliner,N., Brodsky,R.A., LaCasce,A.S., and Moake,J.L..Decision Support in Medicine, LLC, Wilmington, DE2012
• Myeloproliferative Neoplasms: Biology and Therapy 
  Chapter: Hematopoietic cell transplantation for myelofibrosis 
  Page 139 - 150Kerbauy,D.M.B., Deeg,H.J.Editors: Verstovsek,S. and Tefferi,A..Humana Press, New York, NY2011
• Transplant Infections 
  Chapter: Introduction to hematopoietic stem cell transplantation 
  Page 1 - 12Rezvani,A.R., Deeg,H.J.Editors: Bowden,R., Ljungman,P., and Snydman,D.R..Lippincott Williams & Wilkins, Philadelphia, PAEdition Thir,2010
• Hematopoietic Stem Cell Transplantation in Clinical Practice 
  Chapter: Acute graft-versus-host disease 
  Page 387 - 400Deeg,H.J., Flowers,M.E.D.Editors: Treleaven,J. and Barrett,A.J..Elsevier Ltd, Edinburgh, UK2009
• Hematopoietic Stem Cell Transplantation in Clinical Practice 
  Chapter: Chronic graft-versus-host disease 
  Page 401 - 407Flowers,M.E.D., Deeg,H.JEditors: Treleaven,J. and Barrett,A.J..Elsevier Ltd, Edinburgh, UK2009
• Hematology Basic Principles and Practice 
  Chapter: Hematopoietic cell transplantation for acquired nonmalignant diseases and myelodysplastic syndrome 
  Page 1561 - 1576Scott,B.L., Deeg,H.J.Editors: Hoffman,R., Benz,E.J., Jr., Shattil,S.J., Furie,B., Silberstein,L.E., McGlave,P., and Heslop,H..Churchill Livingstone Elsevier, Philadelphia, PAEdition 5th,2009
• Thomas' Hematopoietic Cell Transplantation 
  Chapter: Hematopoietic cell transplantation for myelodysplastic syndrome and myeloproliferative disorders 
  Page 827 - 844Deeg,H.J.Editors: Appelbaum,F.R., Forman,S.J., Negrin,R.S., and Blume,K.G..Wiley-Blackwell, Oxford, UKEdition Four,2009
• Thomas' Hematopoietic Cell Transplantation 
  Chapter: Delayed nonmalignant complications after hematopoietic cell transplantation 
  Page 1620 - 1637Flowers,M.E.D., Deeg,H.J.Editors: Appelbaum,F.R., Forman,S.J., Negrin,R.S., and Blume,K.G..Wiley-Blackwell, Oxford, UKEdition Four,2009
• Chronic Graft Versus Host Disease: Interdisciplinary Management 
  Chapter: Secondary malignancies and other late effects 
  Page 326 - 334Socie,G., Deeg,H.J.Editors: Vogelsang,G.B. and Pavletic,S.Z..Cambridge University Press, New York NY2009
• American Society of Clinical Oncology 2009 Educational Book 
  Chapter: Allogeneic hematopoietic cell transplantation in older patients with myelodysplastic syndrome 
  Page 420 - 424Deeg,H.J.American Society of Clinical Oncology, Alexandria, VA2009
• Hematopoietic Stem Cell Transplantation 
  Chapter: Acute graft-versus-host disease 
  Page 589 - 620Benesch,M., Deeg,H.J.Editors: Soiffer,R.J..Humana Press, Totowa, NJEdition Seco,2008
• Hematopoietic Stem Cell Transplantation 
  Chapter: Allogeneic hematopoietic cell transplantation for patients with myelodysplastic syndrome and myeloproliferative disorders 
  Page 167 - 182Ramakrishnan,A., Deeg,H.J.Editors: Soiffer,R.J..Humana Press, Totowa, NJEdition Seco,2008
• Cancer Survivorship: Today and Tomorrow 
  Chapter: Medical and psychosocial issues in transplant survivors 
  Page 188 - 214Syrjala,K.L., Martin,P., Deeg,J., Boeckh, M.Editors: Ganz,P.A..Springer Science+Business Media, LLC, New York NY2007
• Oncology: An Evidence-Based Approach 
  Chapter: Medical and psychosocial issues in transplant survivors 
  Page 1902 - 1928Syrjala,K.L., Martin,P., Deeg,J., Boeckh, MEditors: Chang,A.E., Ganz,P.A., Hayes,D.F., Kinsella,T.J., Pass,H.I., Schiller,J.H., Stone,R.M., and Strecher,V.J..Springer Science + Business Media, Inc., New York, NY2006
• Myelodysplastic Syndromes: Clinical and Biological Advances 
  Chapter: Hematopoietic cell transplantation for myelodysplastic syndromes 
  Page 243 - 262Deeg,H.J., Scott,B.Editors: Greenberg, P.L..Cambridge University Press, Cambridge, UK2006
• Hematologic Malignancies: Myelodysplastic Syndromes 
  Editors: Deeg,H.J., Bowen,D.T., Gore,S.D., Haferlach,T., Le Beau,M.M., Niemeyer,C..Springer, Heidelberg, Germany2006
• Hematologic Malignancies: Myelodysplastic Syndromes 
  Chapter: Second malignancies 
  Page 135 - 136Deeg,H.J.Editors: Deeg,H.J., Bowen,D.T., Gore,S.D., Haferlach,T., Le Beau,M.M., and Niemeyer,C.Springer, Heidelberg, Germany2006
• Join now to see all

Abstracts/Posters

• Determining eligibility for autologous hematopoietic cell transplantation
  Holmberg,L.A., Deeg,H.J., Sandmaier,B.M., 1/1/2011

Other

• Hematopoietic cell transplantation for myelofibrosis 
  Gerds,A.T., Scott,B.L., Deeg,H.J., Myeloproliferative Neoplasms: A Clinicians Guide App (eBook),
  1/15/2014
• Allogeneic bone marrow transplantation in children with myelodysplastic syndrome or juvenile myelomonocytic leukemia: the Seattle experience 
  Yusuf, U., Frangoul, H.A., Gooley, T.A., Woolfrey, A.E., Carpenter, P.A., Andrews, R.G., Deeg, H.J., Appelbaum, F.R., Anasetti, C., Storb, R., Sanders, J.E, Bone Marrow Transplant. Advance online
  1/2/2004
• Hematopoietic cell transplantation for myelodysplastic syndromes (MDS). 
  Scott,B., Deeg,H.J., The MDS News
  1/1/2004
• Myelodysplastic Syndromes 
  Greenberg, P.L., Baer, M., Bennett, J.M., Bloomfield, C.D., DeCastro, C.M., Deeg, H.J., Devetten, M., Emanuel, P.D., Erba, H.P., Estey, E., Foran, J., Gore, S.D., Mill..., National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology v.1. 2005
  http://www.nccn.org/professionals/physician_gls/PDF/mds.pdf
  1/1/2004
• Ueber das Rectum-Carcinom unter besonderer Beruecksichtigung des TNM-Systems, Inaugural Dissertation 
  Deeg, H.J., University of Bonn, School of Medicine
  1/1/1972
• Determining eligibility for allogeneic hematopoietic cell transplantation 
  Deeg HJ, Sandmaier BM
  http://www.uptodate.com/contents/determining-eligibility-for-allogeneic-hematopoietic-cell-transplan
  UpToDate, Wolters Kluwer Health - 2013-03-29
• Determining eligibility for autologous hematopoietic cell transplantation 
  Deeg HJ, Sandmaier BM, Holmberg LA
  http://www.uptodate.com/contents/determining-eligibility-for-autologous-hematopoietic-cell-transplan
  UpToDate, Wolters Kluwer Health - 2012-03-06
• Join now to see all